Glutamate uptake into synaptic vesicles: competitive inhibition by bromocriptine

Area of Science:

• Neuroscience
• Neuropharmacology
• Molecular Biology

Background:

• Synaptic vesicles play a crucial role in glutamatergic neurotransmission via L-glutamate uptake.
• Understanding the mechanisms of vesicular glutamate transport is vital for neurological research.

Purpose of the Study:

• To investigate the effect of ergot derivatives on ATP-dependent L-glutamate uptake into synaptic vesicles.
• To identify specific inhibitors of the vesicular glutamate transporter.

Main Methods:

• Inhibition assays using various ergot compounds (bromocriptine, ergotamine, ergocristine, ergonovine, lergotrile, methysergide).
• Determination of IC50 values for inhibitory compounds.
• Kinetic analysis to elucidate the mechanism of inhibition.

Main Results:

• Bromocriptine demonstrated potent, selective inhibition of vesicular glutamate uptake (IC50 = 22 μM).
• Other peptide-containing ergopeptines showed weaker inhibition; peptide-devoid ergots had minimal effect.
• Kinetic data suggest bromocriptine competes with L-glutamate for the transporter's binding site.

Conclusions:

• Bromocriptine serves as a valuable prototype inhibitor for studying the vesicular glutamate translocator.
• This research paves the way for developing more specific inhibitors targeting this crucial neurotransmitter transport system.